FATE
Fate Therapeutics
$2.17
+$0.10 (+4.83%)Oct 28, 2026
Key metrics
The numbers that frame FATE today
- Market cap
- $260.01M
- Gross margin
- 100%
- EV / Sales
- 45.2
- ROIC
- -42.4%
- Div yield
- 0%
- Debt / equity
- 0.5
- 52wk Low
- $0.95
- 52wk High
- $3.23
Growth
Revenue and earnings trend for FATE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about FATE
Is Fate Therapeutics a good buy?
Hold. Fate Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Fate Therapeutics is selling at a very high price.
What is the market capitalization of FATE?
Fate Therapeutics's market capitalization is $260.01M.
What is the 52-week high for FATE stock?
The 52-week high for Fate Therapeutics is $3.23. The current close of $2.17 is 32.8% below that high.
What is the 52-week low for FATE stock?
The 52-week low for Fate Therapeutics is $0.95. The current close of $2.17 is 128.4% above that low.
Does FATE stock pay dividends?
Fate Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for FATE?
Fate Therapeutics's Debt / Equity ratio is 0.49.